Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-20

Clinical Trial Update: Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation [NA]

View source ↗

Summary

A clinical trial evaluating petrolatum for initial symptoms of nonscalp seborrheic dermatitis and prevention of exacerbation has been terminated. The sponsor li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Petrolatum (petrolatum)

Snippet

Sponsor: Ascension Health | Conditions: Seborrheic Dermatitis | NA | Status: TERMINATED